First-in-human study to assess the safety and feasibility of intra-articular administration of allogeneic engineered gingival fibroblasts (aeGF) in participants with knee osteoarthritis.
This is a very early study looking at a new way to treat knee osteoarthritis, a common condition that causes joint pain. Scientists want to find out if giving injections of specially grown cells, called gingival fibroblasts, directly into the knee joint is safe for people and if the procedure works as expected. This is the first time humans will receive this experimental treatment, so it's a 'first-in-human' study. The main goal is to check for any safety concerns and to make sure the treatment can be given without major problems, rather than to see if it cures the condition. Men and women over 18 can take part if they have knee osteoarthritis.
At a glance
What is this study about?
This study is about a new and experimental approach to treating knee osteoarthritis. Osteoarthritis is a common type of arthritis where the protective cartilage on the ends of your bones wears down over time, causing pain, swelling, and stiffness in your joints, often in the knees. Current treatments can help manage symptoms, but they don't reverse the damage.
In this study, researchers are exploring if a special type of cell, called 'engineered gingival fibroblasts' (aeGF), can be safely injected into the knee joint. These cells come from gum tissue and have been grown in a lab. The idea is that these cells might have properties that could help the knee joint, but this is still very much being investigated. Because this is the very first time this treatment is being tried in people, it's called a 'first-in-human' study. This means the main focus is on safety before anything else.
The main purpose of this study is to see if giving these cell injections is safe for people with knee osteoarthritis, and if the procedure itself is practical and possible to carry out. Researchers will be carefully monitoring participants for any side effects or problems after the injections. It's important to remember that this study is not designed to see how well the treatment works to improve your osteoarthritis, but rather to ensure it can be safely given before larger studies can happen down the line.
Key takeaways
- This is a 'first-in-human' study for knee osteoarthritis.
- The main goal is to check the safety and feasibility of a new cell injection.
- The treatment involves injecting special cells from gum tissue into the knee.
- Participants must be adults (18+) with knee osteoarthritis.
- You won't know if the treatment works in this early safety study.
- Participation involves clinic visits for monitoring after the injection.
Who may be eligible?
To be considered for this study, you must be an adult aged 18 years or older. The study is open to both men and women.
The main requirement is that you have been diagnosed with knee osteoarthritis. This is a common condition where the cartilage in your knee joint wears down over time, causing pain and stiffness. If you have been told by your doctor that you have knee osteoarthritis, you might be suitable.
There will also be other specific health requirements and tests to make sure that the treatment is safe for you. These will be explained in detail by the study team if you express interest. For example, they might check for other health conditions or medications you are taking that could affect your participation.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you have a diagnosis of knee osteoarthritis?
- Are you able to attend regular clinic visits?
- Are you generally in good health apart from your knee osteoarthritis?
- Are you willing to receive an injection into your knee joint?
What does participation involve?
If you decide to take part in this study, you will receive an injection of the study treatment directly into your knee joint. This will be done by a medical professional. After the injection, you will have several visits to the clinic so that the study team can carefully check on your health and how you are feeling. They will be looking for any signs of side effects and making sure you are recovering well.
During these visits, you can expect to have different assessments, which might include talking about your pain and any changes you notice, physical examinations of your knee, and possibly blood tests or scans. These regular check-ups are very important for gathering information about the safety of the treatment. The total length of your involvement in the study, including all follow-up visits, will be explained fully by the study team.
Potential risks and benefits
Locations (1)
- —UnverifiedDenmark
Common questions
What is knee osteoarthritis?
Knee osteoarthritis is a common condition where the smooth cartilage in your knee joint wears away, leading to pain, stiffness, and sometimes swelling.
What are 'gingival fibroblasts'?
These are special cells originally found in gum tissue. In this study, they are grown in a lab and then carefully injected into the knee, after being specially prepared.
Is this a cure for knee osteoarthritis?
No, this is a very early-stage study to check if the treatment is safe and possible to give. It's not designed to find a cure, but rather to gather important safety information for future research.
Will I get the actual treatment or a dummy injection?
This early study usually involves everyone receiving the active treatment. However, the study team will explain the exact details upon your inquiry.
What happens after the injection?
You'll have several follow-up visits to the clinic so the study team can monitor your health, check for any side effects, and see how you're feeling.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.